US pharmaceutical packaging demand will expand 7.0 percent annually to $11 billion in 2010. Over the next several years, the strongest influence on the US market for pharmaceutical packaging products
June 26, 2007 (Press Release) --
Demand to reach $11 billion in 2010
US pharmaceutical packaging demand will expand 7.0 percent annually to $11 billion in 2010. Over the next several years, the strongest influence on the US market for pharmaceutical packaging products will involve the adoption of new regulations and standards that address such issues as patient drug compliance, drug dispensing errors, and drug counterfeiting and diversion. An increased focus on these issues will expand growth opportunities for high valueadded containers, closures and accessories, especially blister packs, tamper-evident closures and RFID labels. In another area, the widening availability of medicines based on biotechnology, nanotechnology and other advanced disciplines, coupled with the commercialization of innovative drug delivery systems and dosage formulations, will prompt the pharmaceutical industry to upgrade the quality and performance properties of packaging configurations. This trend will particularly benefit demand for functional containers, such as prefillable inhalers and syringes, which provide for more precise drug administration and enhanced infection prevention.
Prefillable inhalers, syringes to pace growth in primary containers
Demand for primary pharmaceutical containers will increase 7.6 percent per year through 2010 to $7.5 billion. Prefillable inhalers and prefillable syringes will generate the fastest growth opportunities among all pharmaceutical packaging products based on performance advantages in drug delivery. Plastic bottles will sustain the largest share of unit demand based on low cost, versatility, availability, and ongoing quality and design improvements. Greater applications in both solid and liquid oral medications will create above average growth prospects for these containers. Pharmaceutical blister packaging will post strong demand gains based on its adaptability to unit dose, clinical trial, sample compliance, institutional and over-the-counter container formats. Advances in the changeover features of processing machinery will also benefit growth by making blister packaging more costefficient in small-volume drug applications. Equipment upgrades, coupled with trends favoring unit dose packaging, will also boost demand for pouches and strip packs.
Secondary container demand to rise over 5% yearly
The US pharmaceutical market for secondary containers, caps and closures, and packaging accessories will grow 5.1 percent annually to $3.6 billion in 2010. Trends toward high visibility packaging will benefit demand for folding paperboard boxes and display convertible shipping cartons. Demand for child-resistant closures and tamper-evident labels, such as RFID bar coded configurations, will benefit from stricter government and industry standards aimed at preventing drug diversion and drug counterfeiting.
For more information, please visit:
http://www.bharatbook.com/detail.asp?id=8173
US pharmaceutical packaging demand will expand 7.0 percent annually to $11 billion in 2010. Over the next several years, the strongest influence on the US market for pharmaceutical packaging products will involve the adoption of new regulations and standards that address such issues as patient drug compliance, drug dispensing errors, and drug counterfeiting and diversion. An increased focus on these issues will expand growth opportunities for high valueadded containers, closures and accessories, especially blister packs, tamper-evident closures and RFID labels. In another area, the widening availability of medicines based on biotechnology, nanotechnology and other advanced disciplines, coupled with the commercialization of innovative drug delivery systems and dosage formulations, will prompt the pharmaceutical industry to upgrade the quality and performance properties of packaging configurations. This trend will particularly benefit demand for functional containers, such as prefillable inhalers and syringes, which provide for more precise drug administration and enhanced infection prevention.
Prefillable inhalers, syringes to pace growth in primary containers
Demand for primary pharmaceutical containers will increase 7.6 percent per year through 2010 to $7.5 billion. Prefillable inhalers and prefillable syringes will generate the fastest growth opportunities among all pharmaceutical packaging products based on performance advantages in drug delivery. Plastic bottles will sustain the largest share of unit demand based on low cost, versatility, availability, and ongoing quality and design improvements. Greater applications in both solid and liquid oral medications will create above average growth prospects for these containers. Pharmaceutical blister packaging will post strong demand gains based on its adaptability to unit dose, clinical trial, sample compliance, institutional and over-the-counter container formats. Advances in the changeover features of processing machinery will also benefit growth by making blister packaging more costefficient in small-volume drug applications. Equipment upgrades, coupled with trends favoring unit dose packaging, will also boost demand for pouches and strip packs.
Secondary container demand to rise over 5% yearly
The US pharmaceutical market for secondary containers, caps and closures, and packaging accessories will grow 5.1 percent annually to $3.6 billion in 2010. Trends toward high visibility packaging will benefit demand for folding paperboard boxes and display convertible shipping cartons. Demand for child-resistant closures and tamper-evident labels, such as RFID bar coded configurations, will benefit from stricter government and industry standards aimed at preventing drug diversion and drug counterfeiting.
For more information, please visit:
http://www.bharatbook.com/detail.asp?id=8173
Email
Print
SPAM
